13F filing recap · Q4 2019
What did Mairs & Power buy in Q4 2019?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Mairs & Power account, including accounts that belong to no fund below.
Stock value
$8.80B
Positions
220
Estimated turnover
5.3%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
CPE3EURCallon Petroleum Co$5.28Mreported value+1.09M sharesXLETechnology Select Sector SPDR Fund$1.71Mreported value+28.5K sharesPCHPotlatchdeltic Corporation$1.60Mreported value+37.0K sharesVOOVanguard Index Funds$1.24Mreported value+4.2K sharesRETAReata Pharmaceuticals Inc$409.0Kreported value+2.0K sharesBSXBoston Scientific Corp$308.0Kreported value+6.8K sharesDUKDuke Energy Corporation$271.0Kreported value+3.0K sharesBBYBest Buy Co., Inc.$264.0Kreported value+3.0K sharesMOAltria Group, Inc.$250.0Kreported value+5.0K sharesAFLAflac Inc$233.0Kreported value+4.4K sharesSEICSei Investments Company$216.0Kreported value+3.3K sharesCVSCVS Health Corp$213.0Kreported value+2.9K sharesCAHCardinal Health, Inc.$213.0Kreported value+4.2K sharesIEFAiShares Trust$211.0Kreported value+3.2K sharesACNAccenture Plc$211.0Kreported value+1.0K sharesGPCGenuine Parts Co$208.0Kreported value+2.0K sharesSWKStanley Black & Decker, Inc.$207.0Kreported value+1.2K sharesSRTSSensus Healthcare, Inc.$48.0Kreported value+13.7K shares